scientific advisory board
George J. Brewer, M.D.
George J. Brewer, M.D., joined Adeona in 2004 as a Scientific Advisory Board member. He served as the Company’s Senior Vice President of Research & Development from March 2011 through December 2011. Dr. Brewer is the Morton S. and Henrietta Sellner Emeritus Professor of Human Genetics and Internal Medicine at the University of Michigan. He was a member of the National Science Council’s “Committee on Copper in Drinking Water” convened at the request of the Environmental Protection Agency in 2000 to consider the issue of what level of copper in drinking water could be considered “safe”. Dr. Brewer has published over 500 scientific papers, several books and is the inventor of oral zinc therapy approved by the FDA in 1997, now standard of care for chronic Wilson’s disease.
Ashley I. Bush, M.D., Ph.D.
Ashley I. Bush, M.D., Ph.D., is a National Health and Medical Research Council Australia Fellow and Head of the Oxidation Disorders Laboratory for the Mental Health Research Institute, University of Melbourne. He has also served as the Director of the Laboratory for Oxidation Biology, Massachusetts General Hospital and Associate Professor of Psychiatry at Harvard Medical School. A board certified psychiatrist, Dr. Bush earned a Ph.D. in neuroscience at the University of Melbourne, and did postdoctoral research at Harvard. He is also a co-founding scientist of Prana Biotechnology, Ltd. Dr. Bush is the recipient of several awards including the Potamkin Prize for Alzheimer’s disease research from the American Academy of Neurology, the Paul B. Beeson Award in Aging from The National Institute on Aging and the American Federation for Aging Research and the Senator Mark A. Hatfield Award for Clinical Research from the Alzheimer’s Association, and has authored over 170 publications with over 14,000 citations.
George A. Eby
George A. Eby is a pioneer in the development of zinc lozenges as a treatment for the common cold. He has devoted more than 30 years to the study of zinc and is the executive director of the George Eby Research Institute. Mr. Eby was the first researcher to demonstrate with statistical significance that zinc lozenges can reduce the average duration of symptoms of the common cold by approximately seven days. His groundbreaking placebo-controlled, randomized, double-blind clinical study was published in the January 1984 volume of American Society for Microbiology and is available at: pubmedcentral. Mr. Eby’s zinc studies have been cited in several journals, most recently in the "Zinc for the Common Cold Review" prepared by The Cochrane Collaboration® and “Zinc Lozenges May Shorten the Duration of Colds: A Systematic Review” in The Open Respiratory Medicine Journal, both published during 2011.
Ananda S. Prasad, M.D., Ph.D.
Ananda S. Prasad, M.D., Ph.D., a Distinguished Professor of Internal Medicine at Wayne State University School of Medicine and renowned zinc expert, recently received the 2010 Mahidol Award in the Field of Public Health for his groundbreaking research. Among his many achievements, he is credited for identifying zinc deficiency as the underlying cause of growth retardation and hypogonadism that has afflicted millions of children in the developing world. Dr. Prasad estimates that over 2 billion people worldwide currently suffer from zinc deficiency. For over five decades, he has been a vocal advocate of zinc supplementation for diseases characterized by zinc deficiency. Dr. Prasad is the 2007 recipient of the American College of Physicians Award for Outstanding Work in Science as Related to Medicine and has over 200 peer-reviewed publications.